MedPath

TIBELLA

TIBELLA

Approved
DIN Number

02488361

Drug Class

Human

Market Date

Jul 29, 2020

Company
HC

biosyent pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02488361
AIG Number0161430001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03CX01 TIBOLONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:16.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TIBOLONEActive
Strength: 2.5 MG
Monograph: TIBOLONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.